Dihidroergocriptina (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dihidroergocriptina" in Spanish language version.

refsWebsite

Global rank Spanish rank

4^th place

2^nd place

57^th place

3^rd place

399^th place

648^th place

doi.org

Antonini, A; Tolosa, E; Mizuno, Y; Yamamoto, M; Poewe, WH (octubre de 2009). «A reassessment of risks and benefits of dopamine agonists in Parkinson's disease». Lancet neurology 8 (10): 929-37. PMID 19709931. doi:10.1016/S1474-4422(09)70225-X.
Gerlach, M; Double, K; Arzberger, T; Leblhuber, F; Tatschner, T; Riederer, P (octubre de 2003). «Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum.». Journal of neural transmission (Vienna, Austria : 1996) 110 (10): 1119-27. PMID 14523624. doi:10.1007/s00702-003-0027-5.
Parkinson Study, Group (Apr 3, 2002). «Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.». JAMA: the Journal of the American Medical Association 287 (13): 1653-61. PMID 11926889. doi:10.1001/jama.287.13.1653.

Micieli, G.; Cavallini, A.; Marcheselli, S.; Mailland, F.; Ambrosoli, L.; Nappi, G. (1 de abril de 2001). «Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis». International Journal of Clinical Pharmacology and Therapeutics 39 (4): 144-151. ISSN 0946-1965. PMID 11332869. Consultado el 8 de agosto de 2016.

Battistin L, Bardin PG, Ferro-Milone F, Ravenna C, Toso V, Reboldi G (1999). «Alpha-dihydroergocryptine in Parkinson's disease: a multicentre randomized double blind parallel group study.». Acta Neurol Scand 99 (1): 36-42. PMID 9925236.
Antonini, A; Tolosa, E; Mizuno, Y; Yamamoto, M; Poewe, WH (octubre de 2009). «A reassessment of risks and benefits of dopamine agonists in Parkinson's disease». Lancet neurology 8 (10): 929-37. PMID 19709931. doi:10.1016/S1474-4422(09)70225-X.
Gerlach, M; Double, K; Arzberger, T; Leblhuber, F; Tatschner, T; Riederer, P (octubre de 2003). «Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum.». Journal of neural transmission (Vienna, Austria : 1996) 110 (10): 1119-27. PMID 14523624. doi:10.1007/s00702-003-0027-5.
Parkinson Study, Group (Apr 3, 2002). «Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.». JAMA: the Journal of the American Medical Association 287 (13): 1653-61. PMID 11926889. doi:10.1001/jama.287.13.1653.
Micieli, G.; Cavallini, A.; Marcheselli, S.; Mailland, F.; Ambrosoli, L.; Nappi, G. (1 de abril de 2001). «Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis». International Journal of Clinical Pharmacology and Therapeutics 39 (4): 144-151. ISSN 0946-1965. PMID 11332869. Consultado el 8 de agosto de 2016.